ATE336255T1 - Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben - Google Patents

Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben

Info

Publication number: ATE336255T1
Authority: AT; Austria
Prior art keywords: hyaluronic acid; treatment; normotrophic; acid ester; skin scars
Prior art date: 1999-06-29

Application number

AT00952981T

Other languages

English (en)

Inventor

Carbonare Maurizio Dalle

Lanfranco Callegaro

Original Assignee

Fidia Farmaceutici

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-29

Filing date

2000-06-29

Publication date

2006-09-15

2000-06-29 Application filed by Fidia Farmaceutici filed Critical Fidia Farmaceutici

2006-09-15 Application granted granted Critical

2006-09-15 Publication of ATE336255T1 publication Critical patent/ATE336255T1/de

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 3
208000032544 Cicatrix Diseases 0.000 title abstract 2
231100000241 scar Toxicity 0.000 title abstract 2
230000037387 scars Effects 0.000 title abstract 2
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1
239000012620 biological material Substances 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
- A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
- A61L17/06—At least partially resorbable materials
- A61L17/10—At least partially resorbable materials containing macromolecular materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Surgery (AREA)
Vascular Medicine (AREA)
Molecular Biology (AREA)
Materials Engineering (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)

AT00952981T 1999-06-29 2000-06-29 Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben ATE336255T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT1999PD000144A IT1306679B1 (it)	1999-06-29	1999-06-29	Uso dei derivati dell'acido ialuronico per la preparazione dicomposizoni farmaceutiche e biomateriali per la prevenzione della

Publications (1)

Publication Number	Publication Date
ATE336255T1 true ATE336255T1 (de)	2006-09-15

Family

ID=11392667

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00952981T ATE336255T1 (de)	1999-06-29	2000-06-29	Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben

Country Status (8)

Country	Link
US (1)	US8147811B1 (de)
EP (2)	EP1196179B8 (de)
AT (1)	ATE336255T1 (de)
AU (1)	AU6559800A (de)
DE (1)	DE60030124T2 (de)
ES (1)	ES2269169T3 (de)
IT (1)	IT1306679B1 (de)
WO (1)	WO2001000190A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0107653D0 (en) *	2001-03-27	2001-05-16	Bristol Myers Squibb Co	Wound dressing
ITPD20050168A1 (it)	2005-06-01	2006-12-02	Fidia Advanced Biopolymers Srl	Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico
ITPD20050207A1 (it)	2005-07-07	2007-01-08	Fidia Farmaceutici	Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
CN101340887B (zh)	2005-11-09	2014-01-29	科洛斯科技公司	使牙齿增白的组合物及方法
US20100266989A1 (en)	2006-11-09	2010-10-21	Klox Technologies Inc.	Teeth whitening compositions and methods
AU2015201245B2 (en) *	2008-09-02	2016-07-07	Allergan, Inc.	Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
JP5722217B2 (ja)	2008-09-02	2015-05-20	アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエＡｌｌｅｒｇａｎＨｏｌｄｉｎｇｓＦｒａｎｃｅＳ．Ａ．Ｓ．	ヒアルロン酸および／またはその誘導体の糸、その作製方法、ならびにその使用
EA029534B1 (ru)	2008-11-07	2018-04-30	Клокс Текнолоджиз Инк.	Комбинация оксиданта и фотоактиватора для заживления ран
SI3187219T1 (sl)	2008-12-02	2020-09-30	Allergan, Inc.	Injekcijska naprava
DK2453922T3 (en)	2009-07-17	2018-01-02	Klox Tech Inc	ANTIBACTERIAL ORAL COMPOSITION
US11116841B2 (en)	2012-04-20	2021-09-14	Klox Technologies Inc.	Biophotonic compositions, kits and methods
US20130281913A1 (en)	2012-04-20	2013-10-24	Klox Technologies Inc.	Biophotonic compositions and methods for providing biophotonic treatment
ITPD20120173A1 (it)	2012-05-31	2013-12-01	Fidia Farmaceutici	"nuovo sistema di rilascio di proteine idrofobiche"
MX351267B (es)	2012-09-14	2017-10-06	Valeant Pharmaceuticals Int Inc	Composiciones y metodos para blanqueamiento dental.
WO2014165113A1 (en) *	2013-03-12	2014-10-09	Allergan Holdings France S.A.S.	Cross-linked hyaluronic acid threads for treatment of striae
US20140276354A1 (en)	2013-03-14	2014-09-18	Klox Technologies Inc.	Biophotonic materials and uses thereof
US20140350518A1 (en)	2013-05-23	2014-11-27	Allergan, Inc.	Syringe extrusion accessory
KR20210108505A (ko)	2013-07-03	2021-09-02	광동 클록스 바이오메디컬 그룹 씨오., 엘티디	상처를 치료하기 위한 발색단과 겔화제를 포함하는 생체광자성 조성물
US9968745B2 (en)	2014-01-27	2018-05-15	Allergan Holdings France S.A.S.	Substance delivery device
WO2015149177A1 (en)	2014-04-01	2015-10-08	Klox Technologies Inc.	Tissue filler compositions and methods of use
US10029048B2 (en)	2014-05-13	2018-07-24	Allergan, Inc.	High force injection devices
US10226585B2 (en)	2014-10-01	2019-03-12	Allergan, Inc.	Devices for injection and dosing
EP3212826B1 (de)	2014-10-31	2020-10-14	Klox Technologies Inc.	Lichtaktivierbare fasern und textilmedien
BR112017019272A2 (pt)	2015-03-10	2018-05-02	Allergan Pharmaceuticals Holdings Ireland Unlimited Company	injetor de múltiplas agulhas
US10596321B2 (en)	2016-04-08	2020-03-24	Allergan, Inc.	Aspiration and injection device
US10258447B2 (en)	2017-01-24	2019-04-16	Allergan Industrie Sas	Thread insertion devices
US10265151B2 (en)	2017-01-24	2019-04-23	Allergan Industrie Sas	Thread insertion devices
US10595977B2 (en)	2017-01-24	2020-03-24	Allergan Industrie, Sas	Thread insertion devices
US10709444B2 (en)	2017-01-24	2020-07-14	Allergan Industrie Sas	Thread insertion devices
US10820900B2 (en)	2017-01-24	2020-11-03	Allergan Industrie Sas	Thread insertion devices
USD867582S1 (en)	2017-03-24	2019-11-19	Allergan, Inc.	Syringe device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4851521A (en) *	1985-07-08	1989-07-25	Fidia, S.P.A.	Esters of hyaluronic acid
IT1219587B (it) *	1988-05-13	1990-05-18	Fidia Farmaceutici	Polisaccaridi carbossiilici autoreticolati
IT1248934B (it) *	1990-06-01	1995-02-11	Fidia Spa	Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle
US5824335A (en) *	1991-12-18	1998-10-20	Dorigatti; Franco	Non-woven fabric material comprising auto-crosslinked hyaluronic acid derivatives
IT1263316B (it) *	1993-02-12	1996-08-05	Fidia Advanced Biopolymers Srl	Tessuto non tessuto multistrato in cui uno degli strati e' costituito essenzialmente da esteri dell'acido ialuronico
BR9610996A (pt) *	1995-08-29	1999-07-13	Fidia Advanced Biopolymers Srl	Biomateriais para prevenção de ades es pós-cirúrgicas compreendendo derivados de ácidos hialurônico
EP0907721A1 (de) *	1996-05-28	1999-04-14	Brown University Research Foundation	Biologisch abbaubarer träger auf basis von hyaluronan für die gewebewiederherstellung
IT1294797B1 (it) *	1997-07-28	1999-04-15	Fidia Advanced Biopolymers Srl	Uso dei derivati dell'acido ialuronico nella preparazione di biomateriali aventi attivita' emostatica fisica e tamponante

1999
- 1999-06-29 IT IT1999PD000144A patent/IT1306679B1/it active
2000
- 2000-06-29 EP EP00952981A patent/EP1196179B8/de not_active Expired - Lifetime
- 2000-06-29 AU AU65598/00A patent/AU6559800A/en not_active Abandoned
- 2000-06-29 AT AT00952981T patent/ATE336255T1/de active
- 2000-06-29 DE DE60030124T patent/DE60030124T2/de not_active Expired - Lifetime
- 2000-06-29 WO PCT/EP2000/006087 patent/WO2001000190A2/en not_active Ceased
- 2000-06-29 ES ES00952981T patent/ES2269169T3/es not_active Expired - Lifetime
- 2000-06-29 US US10/019,387 patent/US8147811B1/en not_active Expired - Fee Related
- 2000-06-29 EP EP20050027813 patent/EP1712228A3/de not_active Withdrawn

Also Published As

Publication number	Publication date
EP1196179B8 (de)	2006-10-11
EP1712228A2 (de)	2006-10-18
EP1196179A2 (de)	2002-04-17
ITPD990144A1 (it)	2000-12-29
WO2001000190A3 (en)	2001-08-16
DE60030124T2 (de)	2007-03-29
US8147811B1 (en)	2012-04-03
DE60030124D1 (de)	2006-09-28
EP1712228A3 (de)	2009-03-18
AU6559800A (en)	2001-01-31
IT1306679B1 (it)	2001-10-02
EP1196179B1 (de)	2006-08-16
ES2269169T3 (es)	2007-04-01
WO2001000190A2 (en)	2001-01-04

Legal Events

Date

Code

Title

Description

2007-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1196179

Country of ref document: EP

Publication	Publication Date	Title
DE60030124D1 (de)	2006-09-28	Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben
DE10085007T1 (de)	2002-10-10	Antiinfektionszusammensetzungen zur Behandlung von erkranktem Gewebe, wie Lippenherpes
DE60023043T2 (de)	2006-06-14	(S,S)-Reboxetin zur Behandlung von Inkontinenz
DE59911740D1 (de)	2005-04-14	Topisch anwendbare mittel gegen nagelpilzerkrankungen
DE60028863D1 (de)	2006-08-03	Elektrochirurgisches Handstück zur Behandlung von Gewebe
DE60027894D1 (de)	2006-06-14	Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen
MY138883A (en)	2009-08-28	Use of asiatic acid for treatment of cencer
DE60032795D1 (de)	2007-02-15	Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ATE336997T1 (de)	2006-09-15	Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
HK1045816A1 (zh)	2002-12-13	角质细胞生长因子-2制剂
ATE368455T1 (de)	2007-08-15	Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE60017133D1 (de)	2005-02-03	Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose
ATE418552T1 (de)	2009-01-15	Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE60018200D1 (de)	2005-03-24	Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
ATE319473T1 (de)	2006-03-15	Melagatran zur behandlung von entzündungen
DE69929616D1 (de)	2006-04-13	Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
ATE290393T1 (de)	2005-03-15	Milchsäurebakterien zur behandlung und prophylaxe von giardiasis
DK1115375T3 (da)	2006-06-12	Anvendelse af mindst ét 10-hydroxy-2-decensyrederivat i et præparat til at fremme hudafstödning
DE69906532D1 (de)	2003-05-08	Biologisch kompatible und biologisch abbaubare zubereitungen enthaltend hyaluronsäure und deren derivate zur behandlung von geschwüren im verdauungsapparat
ATE252903T1 (de)	2003-11-15	Arzneimittel zur behandlung konvulsivischer zustände
ATE289201T1 (de)	2005-03-15	Zubereitung zur behandlung von flächigen, offenen wunden
ATE226440T1 (de)	2002-11-15	Zusammensetzung zur behandlung von psoriasis
ATE222501T1 (de)	2002-09-15	Tissue-faktor zur beeinflussung von gefässbildung
ATE309807T1 (de)	2005-12-15	Zusammensetzung zur behandlung von atherosklerose,welche ein statin und ex-vivo behandeltes blut enthält
ATE261965T1 (de)	2004-04-15	Bispidin-derivate zur behandlung von herzarrhythmien